The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Zoster Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
Zoster vaccines are two vaccines that have been shown to reduce the rates of herpes zoster (also known as shingles).
The global Zoster Vaccine market size is expected to reach US$ 6142 million by 2029, growing at a CAGR of 10.0% from 2023 to 2029. The market is mainly driven by the significant applications of Zoster Vaccine in various end use industries. The expanding demands from the Government Institution, Private Sector and Other, are propelling Zoster Vaccine market. Live Attenuated Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zoster Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zoster Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zoster Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zoster Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zoster Vaccine covered in this report include GSK, Merck, Sanofi Pasteur, SK chemicals and Green Cross Corp, etc.
The global Zoster Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck
Sanofi Pasteur
SK chemicals
Green Cross Corp
Global Zoster Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zoster Vaccine market, Segment by Type:
Live Attenuated Vaccine
Recombinant
Global Zoster Vaccine market, by Application
Government Institution
Private Sector
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Zoster Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Zoster Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Zoster vaccines are two vaccines that have been shown to reduce the rates of herpes zoster (also known as shingles).
The global Zoster Vaccine market size is expected to reach US$ 6142 million by 2029, growing at a CAGR of 10.0% from 2023 to 2029. The market is mainly driven by the significant applications of Zoster Vaccine in various end use industries. The expanding demands from the Government Institution, Private Sector and Other, are propelling Zoster Vaccine market. Live Attenuated Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Recombinant segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Zoster Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Zoster Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Zoster Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Zoster Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Zoster Vaccine covered in this report include GSK, Merck, Sanofi Pasteur, SK chemicals and Green Cross Corp, etc.
The global Zoster Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GSK
Merck
Sanofi Pasteur
SK chemicals
Green Cross Corp
Global Zoster Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Zoster Vaccine market, Segment by Type:
Live Attenuated Vaccine
Recombinant
Global Zoster Vaccine market, by Application
Government Institution
Private Sector
Other
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Zoster Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Zoster Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Zoster Vaccine Market Overview
1.1 Zoster Vaccine Product Overview
1.2 Zoster Vaccine Market Segment by Type
1.2.1 Live Attenuated Vaccine
1.2.2 Recombinant
1.3 Global Zoster Vaccine Market Size by Type
1.3.1 Global Zoster Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Zoster Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Zoster Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Zoster Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Zoster Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Zoster Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Zoster Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Zoster Vaccine Sales Breakdown by Type (2018-2023)
2 Global Zoster Vaccine Market Competition by Company
2.1 Global Top Players by Zoster Vaccine Sales (2018-2023)
2.2 Global Top Players by Zoster Vaccine Revenue (2018-2023)
2.3 Global Top Players by Zoster Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Zoster Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Zoster Vaccine Market Competitive Situation and Trends
2.5.1 Zoster Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Zoster Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Zoster Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Zoster Vaccine Market
2.8 Key Manufacturers Zoster Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Zoster Vaccine Status and Outlook by Region
3.1 Global Zoster Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Zoster Vaccine Historic Market Size by Region
3.2.1 Global Zoster Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Zoster Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Zoster Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Zoster Vaccine Forecasted Market Size by Region
3.3.1 Global Zoster Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Zoster Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Zoster Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Zoster Vaccine by Application
4.1 Zoster Vaccine Market Segment by Application
4.1.1 Government Institution
4.1.2 Private Sector
4.1.3 Other
4.2 Global Zoster Vaccine Market Size by Application
4.2.1 Global Zoster Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Zoster Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Zoster Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Zoster Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Zoster Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Zoster Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Zoster Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Zoster Vaccine Sales Breakdown by Application (2018-2023)
5 North America Zoster Vaccine by Country
5.1 North America Zoster Vaccine Historic Market Size by Country
5.1.1 North America Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Zoster Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Zoster Vaccine Sales in Value by Country (2018-2023)
5.2 North America Zoster Vaccine Forecasted Market Size by Country
5.2.1 North America Zoster Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Zoster Vaccine Sales in Value by Country (2024-2029)
6 Europe Zoster Vaccine by Country
6.1 Europe Zoster Vaccine Historic Market Size by Country
6.1.1 Europe Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Zoster Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Zoster Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Zoster Vaccine Forecasted Market Size by Country
6.2.1 Europe Zoster Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Zoster Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Zoster Vaccine by Region
7.1 Asia-Pacific Zoster Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Zoster Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Zoster Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Zoster Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Zoster Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Zoster Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Zoster Vaccine Sales in Value by Region (2024-2029)
8 Latin America Zoster Vaccine by Country
8.1 Latin America Zoster Vaccine Historic Market Size by Country
8.1.1 Latin America Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Zoster Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Zoster Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Zoster Vaccine Forecasted Market Size by Country
8.2.1 Latin America Zoster Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Zoster Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Zoster Vaccine by Country
9.1 Middle East and Africa Zoster Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Zoster Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Zoster Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Zoster Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Zoster Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Zoster Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Zoster Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 GSK
10.1.1 GSK Company Information
10.1.2 GSK Introduction and Business Overview
10.1.3 GSK Zoster Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 GSK Zoster Vaccine Products Offered
10.1.5 GSK Recent Development
10.2 Merck
10.2.1 Merck Company Information
10.2.2 Merck Introduction and Business Overview
10.2.3 Merck Zoster Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Merck Zoster Vaccine Products Offered
10.2.5 Merck Recent Development
10.3 Sanofi Pasteur
10.3.1 Sanofi Pasteur Company Information
10.3.2 Sanofi Pasteur Introduction and Business Overview
10.3.3 Sanofi Pasteur Zoster Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Sanofi Pasteur Zoster Vaccine Products Offered
10.3.5 Sanofi Pasteur Recent Development
10.4 SK chemicals
10.4.1 SK chemicals Company Information
10.4.2 SK chemicals Introduction and Business Overview
10.4.3 SK chemicals Zoster Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 SK chemicals Zoster Vaccine Products Offered
10.4.5 SK chemicals Recent Development
10.5 Green Cross Corp
10.5.1 Green Cross Corp Company Information
10.5.2 Green Cross Corp Introduction and Business Overview
10.5.3 Green Cross Corp Zoster Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Green Cross Corp Zoster Vaccine Products Offered
10.5.5 Green Cross Corp Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Zoster Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Zoster Vaccine Industrial Chain Analysis
11.4 Zoster Vaccine Market Dynamics
11.4.1 Zoster Vaccine Industry Trends
11.4.2 Zoster Vaccine Market Drivers
11.4.3 Zoster Vaccine Market Challenges
11.4.4 Zoster Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Zoster Vaccine Distributors
12.3 Zoster Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
